Evidence map›Paper›PMID 36849906›Full record

ArticleBMC medical imaging2023

A quantitative clinical evaluation of simultaneous reconstruction of attenuation and activity in time-of-flight PET.

Haiqiong Zhang, Jingnan Wang, Nan Li, Yue Zhang, Jie Cui, Li Huo, Hui Zhang

Abstract read
In one paragraph

Article in BMC medical imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haiqiong ZhangDepartment of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Jingnan WangDepartment of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Nan LiSinoUnion (Beijing) Healthcare Technologies Co., Ltd, Beijing, 100082, China.
Yue ZhangSinoUnion (Beijing) Healthcare Technologies Co., Ltd, Beijing, 100082, China.
Jie CuiSinoUnion (Beijing) Healthcare Technologies Co., Ltd, Beijing, 100082, China.
Li HuoDepartment of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China. huoli@pumch.cn.
Hui ZhangSinoUnion (Beijing) Healthcare Technologies Co., Ltd, Beijing, 100082, China. hzhang@tsinghua.edu.cn.

Funding

CAMS fund for Rare Diseases Research 2016ZX310174-4National Key Research and Development Program of China 2020YFC2002702Tsinghua University and PUMCH joint fund PTQH201906006Tsinghua University Initiative Scientific Research Program 20191080605
6 · The paper itself

Abstract

backgroundThe maximum likelihood activity and attenuation (MLAA) reconstruction algorithm has been proposed to jointly estimate tracer activity and attenuation at the same time, and proven to be a promising solution to the CT attenuation correction (CT-AC) artifacts in PET images. This study aimed to perform a quantitative evaluation and clinical validation of the MLAA method.

methodsA uniform cylinder phantom filled with

resultsIn quantitative analysis, SUVs in patient's organ ROIs between two methods showed R

conclusionsPET images reconstructed using MLAA are clinically acceptable in terms of image quality as well as quantification and it is a useful tool in clinical practice, especially when CT-AC may cause respiration motion and metal artifacts. Moreover, this study also provides technical reference and data support for the future iteration and development of PET reconstruction technology of SUV accurate quantification.

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyAlgorithmsHumansLiverPolymersRetrospective StudiesFluorodeoxyglucose F18PolymersCT-OSEMMLAAQuantitative evaluationTOF-PET

Identifiers

PMID36849906
PMCPMC9972693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.